☰

Ameae M. Walker - Publications

Affiliations: 
University of California, Riverside, Riverside, CA, United States 
Area:
Biomedical Engineering
Website:
https://stemcells.ucr.edu/stem-cell-center/faculty/ameae-walker
Tree Info Similar researchers PubMed Report error

95 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Chen YL, Lowery AT, Lin S, Walker AM, Chen KE. Tumor cell-derived asymmetric dimethylarginine regulates macrophage functions and polarization. Cancer Cell International. 22: 351. PMID 36376929 DOI: 10.1186/s12935-022-02769-7  0.56
2022 Chen KE, Walker AM. Splice modulating oligomers as cancer therapeutics. Genes & Cancer. 13: 46-48. PMID 36051750 DOI: 10.18632/genesandcancer.222  0.512
2021 Chen KE, Ghosh M, Rivera L, Lin S, Kumar A, Swaminathan S, Lorenson MY, Walker AM. Prolactin enhances T regulatory cell promotion of breast cancer through the long form prolactin receptor. Translational Oncology. 14: 101195. PMID 34375938 DOI: 10.1016/j.tranon.2021.101195  0.587
2021 Ghosh MK, Chen KE, Dill-Garlow R, Ma LJ, Yonezawa T, Itoh Y, Rivera L, Radecki KC, Wu QP, Arnold AP, Muller HK, Walker AM. Sex Differences in the Immune System Become Evident in the Perinatal Period in the Four Core Genotypes Mouse. Frontiers in Endocrinology. 12: 582614. PMID 34122327 DOI: 10.3389/fendo.2021.582614  0.743
2019 Lorenson MY, Chen KE, Walker AM. Enzyme-linked oligonucleotide hybridization assay for direct oligo measurement in blood. Biology Methods & Protocols. 4: bpy014. PMID 32395619 DOI: 10.1093/Biomethods/Bpy014  0.556
2019 Dill-Garlow R, Chen KE, Walker AM. Sex Differences in Mouse Popliteal Lymph Nodes. Scientific Reports. 9: 965. PMID 30700819 DOI: 10.1038/S41598-018-37175-5  0.595
2018 Lopez T, Chuan C, Ramirez A, Chen KE, Lorenson MY, Benitez C, Mustafa Z, Pham H, Sanchez R, Walker AM, Ge X. Epitope specific affinity maturation improved stability of potent protease inhibitory antibodies. Biotechnology and Bioengineering. PMID 30102763 DOI: 10.1002/Bit.26814  0.554
2018 Chen KE, Chen C, Lopez T, Radecki KC, Bustamante K, Lorenson MY, Ge X, Walker AM. Use of a novel camelid-inspired human antibody demonstrates the importance of MMP-14 to cancer stem cell function in the metastatic process. Oncotarget. 9: 29431-29444. PMID 30034628 DOI: 10.18632/Oncotarget.25654  0.6
2017 Chen KE, Bustamante K, Nguyen V, Walker AM. Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol. Oncotarget. PMID 28422740 DOI: 10.18632/Oncotarget.16755  0.609
2017 Chen KE, Walker A. Abstract LB-211: Phenotypic change specific to tumor-infiltrating regulatory T cells by LFPRLR knockdown Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-211  0.353
2016 Dill R, Walker AM. Role of Prolactin in Promotion of Immune Cell Migration into the Mammary Gland. Journal of Mammary Gland Biology and Neoplasia. PMID 27900586 DOI: 10.1007/S10911-016-9369-0  0.366
2016 Chen KE, Walker AM. Prolactin inhibits a major tumor-suppressive function of wild type BRCA1. Cancer Letters. PMID 26970274 DOI: 10.1016/J.Canlet.2016.03.007  0.644
2015 Yonezawa T, Chen KE, Ghosh MK, Rivera L, Dill R, Ma L, Villa PA, Kawaminami M, Walker AM. Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancer. Cancer Letters. PMID 26095602 DOI: 10.1016/J.Canlet.2015.06.010  0.766
2015 David CN, Frias ES, Elix CC, McGovern KE, Walker AM, Eichler JF, Wilson EH. Antitumor activity of a polypyridyl chelating ligand: in vitro and in vivo inhibition of glioma. Asn Neuro. 7. PMID 25732707 DOI: 10.1177/1759091415572365  0.313
2015 Huang KT, Tan D, Chen KH, Walker AM. Blockade of estrogen-stimulated proliferation by a constitutively-active prolactin receptor having lower expression in invasive ductal carcinoma. Cancer Letters. 358: 152-60. PMID 25527452 DOI: 10.1016/J.Canlet.2014.12.031  0.802
2014 Tan D, Chen KE, Deng C, Tang P, Huang J, Mansour T, Luben RA, Walker AM. An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma. Cancer Letters. 346: 148-57. PMID 24384092 DOI: 10.1016/J.Canlet.2013.12.030  0.747
2014 Chen KE, Ghosh MK, Yonezawa T, Walker AM. Abstract LB-255: Prolactin drives the recruitment of tumor Tregs and Treg-mediated metastasis Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-255  0.416
2013 Yonezawa T, Chen KE, Duong D, Ma L, Ghosh M, Kawaminami M, Walker AM. Abstract 2444: Anticancer effects of antimaia in a highly metastatic, orthotopic, immunologically competent model of breast cancer. Cancer Research. 73: 2444-2444. DOI: 10.1158/1538-7445.Am2013-2444  0.705
2012 Lorenson MY, Ueda EK, Chen KE, Walker AM. A major prolactin-binding complex on human milk fat globule membranes contains cyclophilins A and B: the complex is not the prolactin receptor. American Journal of Physiology. Endocrinology and Metabolism. 302: E585-94. PMID 22205628 DOI: 10.1152/Ajpendo.00480.2011  0.599
2012 Lorenson MY, Liu JW, Patel T, Walker AM. Intragranular prolactin phosphorylation and kallikrein cleavage are regulated by zinc and other divalent cations. Endocrine. 4: 249-57. PMID 21153281 DOI: 10.1007/Bf02738691  0.376
2012 Kawaminami M, Okazaki K, Uchida S, Marumoto N, Takehara K, Kurusu S, Hashimoto I, Walker AM. Intrapituitary distribution and effects of annexin 5 on prolactin release. Endocrine. 5: 9-14. PMID 21153088 DOI: 10.1007/Bf02738650  0.376
2011 Ueda EK, Huang K, Nguyen V, Ferreira M, Andre S, Walker AM. Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. Cell and Tissue Research. 346: 175-89. PMID 22081226 DOI: 10.1007/S00441-011-1253-Z  0.754
2011 Tan D, Chen KE, Khoo T, Walker AM. Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists. Cancer Letters. 310: 101-8. PMID 21775057 DOI: 10.1016/J.Canlet.2011.06.014  0.427
2010 Yang NY, Lopez-Bergami P, Goydos JS, Yip D, Walker AM, Pasquale EB, Ethell IM. The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand. Pigment Cell & Melanoma Research. 23: 684-7. PMID 20649938 DOI: 10.1111/J.1755-148X.2010.00745.X  0.35
2010 Terasaki Y, Yahiro K, Pacheco-Rodriguez G, Steagall WK, Stylianou MP, Evans JF, Walker AM, Moss J. Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 182: 531-9. PMID 20413627 DOI: 10.1164/Rccm.200911-1737Oc  0.333
2010 Tan D, Walker AM. Short form 1b human prolactin receptor down-regulates expression of the long form. Journal of Molecular Endocrinology. 44: 187-94. PMID 19906835 DOI: 10.1677/Jme-09-0101  0.402
2010 Huang KT, Walker AM. Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity. The Prostate. 70: 37-47. PMID 19739126 DOI: 10.1002/Pros.21036  0.744
2010 Chen Y, Huang K, Chen KE, Walker AM. Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor alpha in T47D breast cancer cells. Breast Cancer Research and Treatment. 120: 369-77. PMID 19377875 DOI: 10.1007/S10549-009-0400-7  0.737
2010 Chen KE, Walker AM. Abstract 700: Prolactin negates the ability of BRCA1 to increase p21 expression and the ability of already synthesized p21 to inhibit the cell cycle Cancer Research. 70: 700-700. DOI: 10.1158/1538-7445.Am10-700  0.396
2009 Ueda EK, Soares CR, Bartolini P, DeGuzman A, Lorenson MY, Walker AM. A molecular mimic of phosphorylated prolactin (S179D PRL) secreted by eukaryotic cells has a conformation with an increased positive surface charge compared to that of unmodified prolactin. Biochemistry. 48: 6887-97. PMID 19555049 DOI: 10.1021/Bi9004864  0.389
2009 Helena CV, McKee DT, Bertram R, Walker AM, Freeman ME. The rhythmic secretion of mating-induced prolactin secretion is controlled by prolactin acting centrally. Endocrinology. 150: 3245-51. PMID 19282380 DOI: 10.1210/En.2009-0095  0.377
2009 Deng C, Ueda E, Chen KE, Bula C, Norman AW, Luben RA, Walker AM. Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells. Molecular Endocrinology (Baltimore, Md.). 23: 226-36. PMID 19074549 DOI: 10.1210/Me.2008-0075  0.695
2009 Walker AM. Phosphorylated and nonphosphorylated Prolactin isoforms. Trends in Endocrinology and Metabolism: Tem. 5: 195-200. PMID 18407208 DOI: 10.1016/1043-2760(94)90077-9  0.375
2008 Ma LJ, Walter B, Deguzman A, Muller HK, Walker AM. Trans-epithelial immune cell transfer during suckling modulates delayed-type hypersensitivity in recipients as a function of gender. Plos One. 3: e3562. PMID 18958163 DOI: 10.1371/Journal.Pone.0003562  0.664
2008 Huang K, Ueda E, Chen Y, Walker AM. Paradigm-shifters: phosphorylated prolactin and short prolactin receptors. Journal of Mammary Gland Biology and Neoplasia. 13: 69-79. PMID 18219563 DOI: 10.1007/S10911-008-9072-X  0.802
2008 Tan D, Huang KT, Ueda E, Walker AM. S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain. Biochemistry. 47: 479-89. PMID 18081308 DOI: 10.1021/Bi7013882  0.722
2008 Guzmán EA, Langowski JL, De Guzman A, Muller HK, Walker AM, Owen LB. S179D prolactin diminishes the effects of UV light on epidermal gamma delta T cells. Molecular and Cellular Endocrinology. 280: 6-12. PMID 17945411 DOI: 10.1016/J.Mce.2007.09.004  0.369
2007 Williams VL, DeGuzman A, Dang H, Kawaminami M, Ho TW, Carter DG, Walker AM. Common and specific effects of the two major forms of prolactin in the rat testis. American Journal of Physiology. Endocrinology and Metabolism. 293: E1795-803. PMID 17911340 DOI: 10.1152/Ajpendo.00541.2007  0.752
2007 Wang Y, Chiu CT, Nakamura T, Walker AM, Petridou B, Trousdale MD, Hamm-Alvarez SF, Mircheff AK, Schechter JE. Traffic of endogenous, transduced, and endocytosed prolactin in rabbit lacrimal acinar cells. Experimental Eye Research. 85: 749-61. PMID 17904551 DOI: 10.1016/J.Exer.2007.08.009  0.425
2007 Wu W, Zanello L, Walker AM. S179D prolactin sensitizes human prostate cancer cells such that physiological concentrations of 1, 25 dihydroxy vitamin D3 result in growth inhibition and cell death. The Prostate. 67: 1498-506. PMID 17680631 DOI: 10.1002/Pros.20598  0.378
2007 Walker AM. S179D prolactin: antagonistic agony! Molecular and Cellular Endocrinology. 276: 1-9. PMID 17669587 DOI: 10.1016/J.Mce.2007.06.001  0.362
2007 Ma LJ, Guzmán EA, DeGuzman A, Muller HK, Walker AM, Owen LB. Local cytokine levels associated with delayed-type hypersensitivity responses: modulation by gender, ovariectomy, and estrogen replacement. The Journal of Endocrinology. 193: 291-7. PMID 17470520 DOI: 10.1677/Joe-06-0024  0.671
2007 Wang Y, Chiu CT, Nakamura T, Walker AM, Petridou B, Trousdale MD, Hamm-Alvarez SF, Schechter JE, Mircheff AK. Elevated prolactin redirects secretory vesicle traffic in rabbit lacrimal acinar cells. American Journal of Physiology. Endocrinology and Metabolism. 292: E1122-34. PMID 17164431 DOI: 10.1152/Ajpendo.00381.2006  0.399
2006 Walker AM. Therapeutic potential of S179D prolactin--from prostate cancer to angioproliferative disorders: the first selective prolactin receptor modulator. Expert Opinion On Investigational Drugs. 15: 1257-67. PMID 16989600 DOI: 10.1517/13543784.15.10.1257  0.406
2006 Wu W, Chen YH, Ueda E, Tan D, Bartolini P, Walker AM. Different forms of prolactin have opposing effects on the expression of cell cycle regulatory proteins in differentiated mammary epithelial cells. Oncology Research. 16: 75-84. PMID 16898268 DOI: 10.3727/000000006783981233  0.702
2006 Ueda EK, Lo HL, Bartolini P, Walker AM. S179D prolactin primarily uses the extrinsic pathway and mitogen-activated protein kinase signaling to induce apoptosis in human endothelial cells. Endocrinology. 147: 4627-37. PMID 16840547 DOI: 10.1210/En.2006-0348  0.377
2006 Soares CRJ, Glezer A, Okazaki K, Ueda EKM, Heller SR, Walker AM, Goffin V, Bartolini P. Physico-chemical and biological characterizations of two human prolactin analogs exhibiting controversial bioactivity, synthesized in Chinese hamster ovary (CHO) cells Protein Expression and Purification. 48: 182-194. PMID 16814566 DOI: 10.1016/J.Pep.2006.04.013  0.359
2006 Ueda E, Ozerdem U, Chen YH, Yao M, Huang KT, Sun H, Martins-Green M, Bartolini P, Walker AM. A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone. Endocrine-Related Cancer. 13: 95-111. PMID 16601282 DOI: 10.1677/Erc.1.01076  0.787
2006 Ma LJ, Guzmán EA, DeGuzman A, Walter B, Muller HK, Walker AM, Owen LB. Unexpected effects of UVB in IL-10 transgenic mice: normalization of contact hypersensitivity response. Archives of Dermatological Research. 297: 417-20. PMID 16389560 DOI: 10.1007/S00403-005-0634-0  0.645
2006 Langenheim JF, Tan D, Walker AM, Chen WY. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists. Molecular Endocrinology (Baltimore, Md.). 20: 661-74. PMID 16269515 DOI: 10.1210/Me.2005-0360  0.382
2006 Ueda E, Soares C, Walker A, Bartolini P. Microbial Cell Factories. 5: P17. DOI: 10.1186/1475-2859-5-S1-P17  0.37
2005 Guzmán EA, Chen YH, Langowski JL, De Guzman A, Lo HL, Walter B, Muller HK, Walker AM, Owen LB. Abrogation of delayed type hypersensitivity response to Candida albicans produced by a molecular mimic of phosphorylated prolactin. Journal of Neuroimmunology. 170: 31-40. PMID 16169603 DOI: 10.1016/J.Jneuroim.2005.08.009  0.655
2005 Wu W, Ginsburg E, Vonderhaar BK, Walker AM. S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells. Cancer Research. 65: 7509-15. PMID 16103106 DOI: 10.1158/0008-5472.Can-04-3350  0.455
2005 Naylor MJ, Oakes SR, Gardiner-Garden M, Harris J, Blazek K, Ho TW, Li FC, Wynick D, Walker AM, Ormandy CJ. Transcriptional changes underlying the secretory activation phase of mammary gland development. Molecular Endocrinology (Baltimore, Md.). 19: 1868-83. PMID 15705664 DOI: 10.1210/Me.2004-0254  0.405
2005 Tan D, Johnson DA, Wu W, Zeng L, Chen YH, Chen WY, Vonderhaar BK, Walker AM. Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells. Molecular Endocrinology (Baltimore, Md.). 19: 1291-303. PMID 15695371 DOI: 10.1210/Me.2004-0304  0.667
2004 Huang KT, Chen YH, Walker AM. Inaccuracies in MTS assays: major distorting effects of medium, serum albumin, and fatty acids. Biotechniques. 37: 406, 408, 410-2. PMID 15470895 DOI: 10.2144/04373St05  0.754
2003 Schroeder MD, Brockman JL, Walker AM, Schuler LA. Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL. Endocrinology. 144: 5300-7. PMID 12970160 DOI: 10.1210/En.2003-0826  0.48
2003 Wu W, Coss D, Lorenson MY, Kuo CB, Xu X, Walker AM. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways. Biochemistry. 42: 7561-70. PMID 12809512 DOI: 10.1021/Bi034217S  0.773
2003 Johnson TE, Vue M, Brekhus S, Khong A, Ho TW, Walker AM. Unmodified prolactin (PRL) promotes PRL secretion and acidophil hypertrophy and is associated with pituitary hyperplasia in female rats. Endocrine. 20: 101-10. PMID 12668874 DOI: 10.1385/Endo:20:1-2:101  0.403
2003 Xu X, Wu W, Williams V, Khong A, Chen YH, Deng C, Walker AM. Opposite effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin on morphology and the expression of prostate specific genes in the normal rat prostate. The Prostate. 54: 25-33. PMID 12481252 DOI: 10.1002/Pros.10168  0.764
2002 Yang L, Lii S, Kuo B, Buckley A, Buckley D, Chen C, Xu X, Coss D, Walker AM. Maternal prolactin composition can permanently affect epidermal gammadeltaT cell function in the offspring. Developmental and Comparative Immunology. 26: 849-60. PMID 12377224 DOI: 10.1016/S0145-305X(02)00036-8  0.763
2002 Kuo BC, Wu W, Xu X, Yang L, Chen C, Coss D, Birdsall B, Nasseri D, Walker AM. Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes β-casein gene expression in the rat mammary gland Cell and Tissue Research. 309: 429-437. PMID 12195299 DOI: 10.1007/S00441-002-0598-8  0.772
2002 Tuazon PT, Lorenson MY, Walker AM, Traugh JA. p21-activated protein kinase gamma-PAK in pituitary secretory granules phosphorylates prolactin. Febs Letters. 515: 84-8. PMID 11943200 DOI: 10.1016/S0014-5793(02)02444-4  0.38
2001 Xu X, Kreye E, Kuo CB, Walker AM. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice. Cancer Research. 61: 6098-104. PMID 11507059  0.567
2001 Yang L, Kuo CB, Liu Y, Coss D, Xu X, Chen C, Oster-Granite ML, Walker AM. Administration of unmodified prolactin (U-PRL) and a molecular mimic of phosphorylated prolactin (PP-PRL) during rat pregnancy provides evidence that the U-PRL:PP-PRL ratio is crucial to the normal development of pup tissues Journal of Endocrinology. 168: 227-238. PMID 11182760 DOI: 10.1677/Joe.0.1680227  0.767
2000 Coss D, Yang L, Kuo CB, Xu X, Luben RA, Walker AM. Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat American Journal of Physiology - Endocrinology and Metabolism. 279: E1216-E1225. PMID 11093907 DOI: 10.1152/Ajpendo.2000.279.6.E1216  0.772
1999 Coss D, Kuo CB, Yang L, Ingleton P, Luben R, Walker AM. Dissociation of Janus Kinase 2 and Signal Transducer and Activator of Transcription 5 Activation after Treatment of Nb2 Cells with a Molecular Mimic of Phosphorylated Prolactin1. Endocrinology. 140: 5087-5094. PMID 28200725 DOI: 10.1210/endo.140.11.7104  0.774
1999 Coss D, Kuo CB, Yang L, Ingleton P, Luben R, Walker AM. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin Endocrinology. 140: 5087-5094. PMID 10537136 DOI: 10.1210/Endo.140.11.7104  0.789
1998 Kuo CB, Coss D, Walker AM. Prolactin receptor antagonists Endocrine. 9: 121-131. PMID 9867245 DOI: 10.1385/Endo:9:2:121  0.693
1998 Chen TJ, Kuo CB, Tsai KF, Liu JOW, Chen DY, Walker AM. Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone Endocrinology. 139: 609-616. PMID 9449632 DOI: 10.1210/ENDO.139.2.5758  0.303
1997 Liu JW, Dawson DD, Peters CE, Baker MA, Walker AM. Estrogen replacement in ovariectomized rats results in physiologically significant levels of circulating progesterone, and co-administration of progesterone markedly reduces the circulating estrogen. Endocrine. 6: 125-31. PMID 9225126 DOI: 10.1007/Bf02738955  0.367
1996 Lorenson MY, Patel T, Liu JW, Walker AM. Prolactin (PRL) is a zinc-binding protein. I. Zinc interactions with monomeric PRL and divalent cation protection of intragranular PRL cysteine thiols. Endocrinology. 137: 809-16. PMID 8603589 DOI: 10.1210/Endo.137.3.8603589  0.361
1996 Wang YF, Liu JW, Mamidi M, Walker AM. Identification of the major site of rat prolactin phosphorylation as serine 177. The Journal of Biological Chemistry. 271: 2462-9. PMID 8576208 DOI: 10.1074/Jbc.271.5.2462  0.308
1995 Walker AM, Montgomery DW, Saraiya S, Ho TWC, Garewal HS, Wilson J, Lorand L. Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes Proceedings of the National Academy of Sciences of the United States of America. 92: 3278-3282. PMID 7724552 DOI: 10.1073/Pnas.92.8.3278  0.369
1995 Langford C, Kadowaki J, Walker AM. In vitro glucoregulation of prolactin secretion. Neuroendocrinology. 56: 838-44. PMID 1369592 DOI: 10.1159/000126314  0.334
1994 Krown KA, Wang YF, Walker AM. Autocrine interaction between prolactin and its receptor occurs intracellularly in the 235-1 mammotroph cell line. Endocrinology. 134: 1546-52. PMID 8119197 DOI: 10.1210/Endo.134.3.8119197  0.418
1993 Wang YF, Walker AM. Dephosphorylation of standard prolactin produces a more biologically active molecule: evidence for antagonism between nonphosphorylated and phosphorylated prolactin in the stimulation of Nb2 cell proliferation. Endocrinology. 133: 2156-60. PMID 8404666 DOI: 10.1210/Endo.133.5.8404666  0.444
1992 Krown KA, Wang YF, Ho TW, Kelly PA, Walker AM. Prolactin isoform 2 as an autocrine growth factor for GH3 cells. Endocrinology. 131: 595-602. PMID 1639009 DOI: 10.1210/Endo.131.2.1639009  0.409
1991 Ho TW, Balden E, Chao J, Walker AM. Prolactin (PRL) processing by kallikrein: production of the 21-23.5K PRL-like molecules and inferences about PRL storage in mature secretory granules. Endocrinology. 129: 184-92. PMID 2055182 DOI: 10.1210/Endo-129-1-184  0.332
1990 Greenan J, Lorenson MY, Conconi MV, Walker AM. Alterations in in situ prolactin secretory granule morphology and immunoactivity by thiols and divalent cations. Endocrinology. 126: 512-8. PMID 2294001 DOI: 10.1210/Endo-126-1-512  0.389
1989 Oetting WS, Ho TW, Greenan JR, Walker AM. Production and secretion of the 21-23.5 kDa prolactin-like molecules. Molecular and Cellular Endocrinology. 61: 189-99. PMID 2917685 DOI: 10.1016/0303-7207(89)90130-5  0.416
1989 Ho TW, Greenan JR, Walker AM. Mammotroph autoregulation: the differential roles of the 24K isoforms of prolactin. Endocrinology. 124: 1507-14. PMID 2917523 DOI: 10.1210/Endo-124-3-1507  0.405
1989 Greenan JR, Balden E, Ho TW, Walker AM. Biosynthesis of the secreted 24 K isoforms of prolactin. Endocrinology. 125: 2041-8. PMID 2791977 DOI: 10.1210/Endo-125-4-2041  0.316
1989 Walker AM, Robertson MT, Jones CJ. Distribution of a prolactinlike material in human eccrine sweat glands. The Journal of Investigative Dermatology. 93: 50-3. PMID 2473138 DOI: 10.1111/1523-1747.Ep12277346  0.357
1986 Walker AM. Specific and reversible degranulation of pituitary mammotrophs. Molecular and Cellular Endocrinology. 47: 71-80. PMID 3743889 DOI: 10.1016/0303-7207(86)90017-1  0.33
1986 Oetting WS, Walker AM. Differential isoform distribution between stored and secreted prolactin Endocrinology. 119: 1377-1381. PMID 3732172 DOI: 10.1210/Endo-119-3-1377  0.381
1986 Miller N, Smith PA, Walker AM. Increased dietary leucine changes the rhythm of prolactin secretion. Metabolism-Clinical and Experimental. 35: 622-626. PMID 3724455 DOI: 10.1016/0026-0495(86)90168-X  0.342
1985 Giss BJ, Walker AM. Mammotroph autoregulation: intracellular fate of internalized prolactin. Molecular and Cellular Endocrinology. 42: 259-67. PMID 4043520 DOI: 10.1016/0303-7207(85)90057-7  0.348
1985 Oetting WS, Walker AM. Intracellular processing of prolactin. Endocrinology. 117: 1565-9. PMID 4029090 DOI: 10.1210/Endo-117-4-1565  0.361
1984 Kadowaki J, Ku N, Oetting WS, Walker AM. Mammotroph autoregulation: Uptake of secreted prolactin and inhibition of secretion Endocrinology. 114: 2060-2067. PMID 6723575 DOI: 10.1210/Endo-114-6-2060  0.416
1984 Conconi MV, Walker AM. Chloroquine affects prolactin secretion and Golgi morphology in the mammotroph. Endocrinology. 114: 725-34. PMID 6697960 DOI: 10.1210/Endo-114-3-725  0.376
1984 Cross M, Walker AM. Physiological concentrations of L-leucine control the release of prolactin from cultured rat pituitary cells. Endocrinology. 114: 80-6. PMID 6690280 DOI: 10.1210/Endo-114-1-80  0.366
1979 Walker AM, Hopkins CR. Dissociation of the porcine anterior pituitary: the kinetics of luteinizing hormone release in response to luteinizing hormone-releasing hormone. Molecular and Cellular Endocrinology. 12: 177-87. PMID 365653 DOI: 10.1016/0303-7207(78)90113-2  0.688
1979 Hopkins CR, Walker AM. Calcium as a second messenger in the stimulation of luteinizing hormone secretion. Molecular and Cellular Endocrinology. 12: 189-208. PMID 103759 DOI: 10.1016/0303-7207(78)90114-4  0.666
1978 Walker AM, Hopkins CR. Stimulation of luteinising hormone release by luteinising hormone-releasing hormone in the porcine anterior pituitary: the role of cyclic AMP. Molecular and Cellular Endocrinology. 10: 327-41. PMID 208900 DOI: 10.1016/0303-7207(78)90046-1  0.688
Show low-probability matches.